Cart
sales@molnova.com
PI3K inhibitor X
CAS No. 956958-53-5
PI3K inhibitor X( XL-147 analog )
Catalog No. M16833 CAS No. 956958-53-5
PI3K inhibitor X (XL-147 analog) is a derivative of XL147 that acts as a reversible inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 85 | In Stock |
|
| 2MG | 30 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 76 | In Stock |
|
| 25MG | 135 | In Stock |
|
| 50MG | 212 | In Stock |
|
| 100MG | 365 | In Stock |
|
| 200MG | 475 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePI3K inhibitor X
-
NoteResearch use only, not for human use.
-
Brief DescriptionPI3K inhibitor X (XL-147 analog) is a derivative of XL147 that acts as a reversible inhibitor.
-
DescriptionPI3K inhibitor X (XL-147 analog) is a derivative of XL147 that acts as a reversible inhibitor of class I PI3Ks with IC50 of 39, 36, 23 and 383 nM for p110α, δ, γ and β respectively; Compound 147 in patent WO2012006552A1.
-
In Vitro——
-
In Vivo——
-
SynonymsXL-147 analog
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorDNA-PK|PI3Kα|PI3Kβ|PI3Kγ|PI3Kδ
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number956958-53-5
-
Formula Weight448.5208
-
Molecular FormulaC21H16N6O2S2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=S(C1=CC=C(C)C=C1)(NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4)=O
-
Chemical NameBenzenesulfonamide, N-[3-(2,1,3-benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Carlos L. Arteaga, et al. Combinations of kinase inhibitors for the treatment of cancer. WO 2012006552 A1.
molnova catalog
related products
-
LX-2343
LX-2343 is an non-ATP competitive PI3K inhibitor that negatively regulates AKT/mTOR signaling.
-
Dactolisib Tosylate
Dactolisib Tosylate (BEZ235 Tosylate) is a dual kinase inhibitor targeting PI3K and mTOR, with IC50 values of 4, 75, 7, and 5 nM for PI3Kα, β, γ, and δ, respectively. It also inhibits mTORC1 and mTORC2.
-
GS-9901
GS-9901 is a selective, orally active and potent PI3Kδ inhibitor (IC50: 1 nM) for the study of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
